P2100036WO01 JP 2021-157929 2021-09-28 Shionogi & Co., Ltd. Pharmaceutical composition comprising triazine derivatives 2 14 AA PAT SOURCE 1..14 MOL_TYPE protein ORGANISM synthetic construct REGION 1..14 NOTE Substrate Peptide KTSAVLQSGFRKME 7 AA PAT REGION 1..7 NOTE Internal Standard Peptide SOURCE 1..7 MOL_TYPE protein ORGANISM synthetic construct KTSAVLQ